“Amyris, Inc. announced that it has developed a yeast strain ready to produce a new fragrance molecule at commercial scale in less than 12 months from the start of strain engineering, and plans to begin manufacturing of this molecule at its Brotas production facility.
The engineered strain was designed, engineered, optimized and scaled for industrial fermentation using Amyris’s advanced synthetic biology platform, showcasing the company’s proprietary HI-RYSE™ (Hyper-Integration for Rapid Yeast Strain Engineering) technology. This achievement adds to the growing number of successfully-scaled molecules produced by Amyris for its partners and consumers, which find use in wide-ranging products such as pharmaceuticals, fuels and specialty chemicals, and are made from renewable plant-based feedstock.(…)”
Cet article n’engage que son auteur/ This article is the sole responsibility of the author.